DZ-2384

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameDZ-2384
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulators
TargetsTubulin
Therapy Area/IndicationsPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiazon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A